Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2153-2161

  Li, Yan ^a   Gobin, Andre M ^a   Dryden, Gerald W ^a   Kang, Xinqin ^a   Xiao, Deyi ^a   Li, Su Ping ^a   Zhang, Guandong ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Ablation; Cancer; Carcinoma; Chitosan; Drug uptake; Gold nanoparticles; Near infrared

Indexed keywords

CASPASE 3; CATALASE; CHITOSAN COATED GOLD GOLD SULFIDE NANOPARTICLE; COPPER ZINC SUPEROXIDE DISMUTASE; GOLD NANOPARTICLE; MANGANESE SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION NEEDLE; BARRETT ESOPHAGUS; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOSCOPE; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; FEASIBILITY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFRARED RADIATION; LASER; LIGHT ABSORPTION; METAPLASIA; MICROENDOSCOPE; MICROFIBER OPTIC PROBE; NEAR INFRARED LIGHT; NONHUMAN; PHOTHERMAL ABLATION THERAPY; RAT; REFLUX ESOPHAGITIS; TUMOR ABLATION; TUMOR CELL DESTRUCTION;

ABLATION; CANCER; CARCINOMA; CHITOSAN; DRUG UPTAKE; GOLD NANOPARTICLES; NEAR INFRARED;

ABLATION TECHNIQUES; ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; GOLD; HUMANS; INFRARED RAYS; METAL NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84879316962     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37140     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Lindblad M, Ye W, Lindgren A, Lagergren J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243:479-485.
3. Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002;99:860-868.
4. Altorki NK, Oliveria S, Schrump DS. Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol. 1997;13:270-280.
5. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol. 1999;26:2-8.
6. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control. 1996;7:322-327.
7. Ku GY, Ilson DH. Role of neoadjuvant therapy for esophageal adenocarcinoma. Surg Oncol Clin N Am. 2009;18:533-546.
8. Lawson JD, Otto K, Grist W, Johnstone PA. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol. 2008;29: 13-19.
9. Boca SC, Potara M, Gabudean AM, Juhem A, Baldeck PL, Astilean S. Chitosan-coated triangular silver nanoparticles as a novel class of bio-compatible, highly effective photothermal transducers for in vitro cancer cell therapy. Cancer Lett. 2011;311:131-140.
10. Moghimi SM. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anticancer Agents Med Chem. 2006;6:553-561.
11. Moon GD, Choi SW, Cai X, etal. A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. J Am Chem Soc. 2011; 133:4762-4765.
12. Moghimi SM, Kissel T. Particulate nanomedicines. Adv Drug Deliv Rev. 2006;58:1451-1455.
13. Avedisian CT, Cavicchi RE, McEuen PL, Zhou X. Nanoparticles for cancer treatment: role of heat transfer. Ann N Y Acad Sci. 2009;1161: 62-73.
14. Cardinal J, Klune JR, Chory E, et al. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery. 2008;144: 125-132.
15. Gentili D, Ori G, Comes FM. Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers. Chem Commun (Camb). 2009;39:5874-5876.
16. Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir. 2006;22:2-5.
17. Niidome T, Yamagata M, Okamoto Y, etal. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release. 2006;114:343-347.
18. Huang X, El Sayed IH, Qian W, El Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128:2115-2120.
19. Chen J, Wang D, Xi J, etal. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett. 2007;7:1318-1322.
20. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 2007;7:1929-1934.
21. Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine. 2006;1:149-154.
22. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209:171-176.
23. Hirsch LR, Stafford RJ, Bankson JA, etal. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A. 2003;100:13549-13554.
24. Day ES, Bickford LR, Slater JH, Riggall NS, Drezek RA, West JL. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. Int J Nanomedicine. 2010;5:445-454.
25. Gobin AM, Watkins EM, Quevedo E, Colvin VL, West JL. Near-infrared-resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small. 2010;6:745-752.
26. Gobin AM, O'Neal DP, Watkins DM, Halas NJ, Drezek RA, West JL. Near infrared laser-tissue welding using nanoshells as an exogenous absorber. Lasers Surg Med. 2005;37:123-129.
27. Gobin AM, Moon JJ, West JL. EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells. Int J Nanomedicine. 2008;3:351-358.
28. Li Y, Wo JM, Su RR, Ray MB, Martin RC. Loss of manganese super-oxide dismutase expression and activity in rat esophagus with external esophageal perfusion. Surgery. 2007;141:359-367.
29. Martin RC, Liu Q, Wo JM, Ray MB, Li Y. Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Clin Cancer Res. 2007;13: 5176-5182.
30. Woodall CE, Li Y, Liu QH, Wo J, Martin RC. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Anticancer Drugs. 2009;20:437-443.
31. Li Y, Woodall C, Wo JM, etal. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma. Cancer Invest. 2008;26:278-285.
32. Schiffman SC, Li Y, Dryden G, Li X, Martin RC. Positive correlation of image analysis by mini-endoscopy with micro-PET scan and histology in rats after esophagoduodenal anastomosis. Surg Endosc. 2010;24: 2835-2841.
33. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58:163-174.
34. Li Y, Wo JM, Su RR, Ray MB, Jones W, Martin RC. Esophageal injury with external esophageal perfusion. J Surg Res. 2005;129:107-113.
35. Li Y, Wo JM, Ellis S, Ray MB, Jones W, Martin RC. A novel external esophageal perfusion model for reflux esophageal injury. Dig Dis Sci. 2006;51:527-532.
36. Fosslien E. Mitochondrial medicine - molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci. 2001;31:25-67.